Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients

Clinical Cancer Research

Volumn 4, Issue 9, 1998, Pages 2125-2128

  Geisler, Jürgen ^a   Geisler, Stephanie B ^a   Lønning, Per E ^a   Smaaland, Rune ^a   Tveit, Kjell M ^c   Refsum, Helga ^b   Ueland, Per M ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FLUOROURACIL; FOLIC ACID; FOLINIC ACID; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; COLORECTAL CANCER; CREATININE BLOOD LEVEL; DRUG ACTIVITY; DRUG MONITORING; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; CREATININE; ERYTHROCYTES; FEMALE; FLUOROURACIL; FOLIC ACID; HOMOCYSTEINE; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; VITAMIN B 12;

EID: 0031712035     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Machover, D., Schwarzenberg, L., Goldschmidt, E., Tourani, J. M., Michalski, B., Hayat, M., Dorval, T., Misset, J. L., Jasmin, C., Maral, R., and Mathé, G. Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot study. Cancer Treat. Rep., 66: 1803-1807, 1982.
2. Machover, D., Goldschmidt, E., Schwarzenberg, L., Vandenbulcke, J. M., Misset, J. L., Chollet, P., and Mathé, G. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluourouracil combined with high-dose folinic acid: an update. Chemotherapia, 4: 369-376, 1985.
3. Petrelli, N., Douglas, H. O., Herrera, L., Russell, D., Stablein, D. M., Bruckner, H. W., Mayer, R. J., Schinella, R., Green, M. D., Muggia, F. M., Megibow, A., Greenwald, E. S., Bukowski, R. M., Harris, J., Levin, B., Gaynor, E., Loutfi, A., Kalser, M. H., Barkin, J. S., Benedetto, P., Wooley, P. V., Nauta, R., Weaver, D. W., and Leichman, L. P. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized Phase III trial. J. Clin. Oncol., 7: 1419-1426, 1989.
4. Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response. J. Clin. Oncol., 10: 896-903, 1992.
5. Evans, R. M., Laskin, J. D., and Hakala, M. T. Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil. Cancer Res., 41: 3288-3295, 1981.
6. Berger, S. H., and Hakala, M. T. Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthetase by 5-fluorouracil. Mol. Pharmacol., 25: 303-309, 1984.
7. Lindenbaum, J., and Allen, R. H. Clinical spectrum and diagnosis of folate deficiency In: L. B. Bailey (ed.), Folate in Health and Disease, pp. 43-73. New York: Marcel Dekker, 1995.
8. Herbert, V. Recommended dietary intakes (RDI) of folate in humans. Am. J. Clin. Nutr., 45: 661-670, 1987.
9. Gunter, E. W., Bowman, B. A., Caudill, S. P., Twite, D. B., Adams, M. J., and Sampson, E. J. Results of an international round robin for serum and whole-blood folate. Clin. Chem., 42: 1689-1694, 1996.
10. Refsum, H., Ueland, P. M., Nygård, O., and Vollset, S. E. Homocysteine and cardiovascular disease. Annu. Rev. Med., 49: 31-62, 1998.
11. Ubbink, J. B. The role of vitamins in the pathogenesis and treatment of hyperhomocysteinaemia. J. Inherit. Metab. Dis., 20: 316-325, 1997.
12. Rasmussen, K., Møller, J., Lyngbak, M., Pedersen, A-M. H., and Dybkjær, L. Age and gender specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin. Chem., 42: 630-636, 1996.
13. Nygård, O., Refsum, H., Ueland, P. M., and Vollset, S. E. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am. J. Clin. Nutr., 67: 263-270, 1997.
14. Refsum, H., Ueland, P. M., and Kvinnsland, S. Acute and long-term effects of high-dose methotrexate treatment on homocysteine in plasma and urine. Cancer Res., 46: 5385-5391, 1986.
15. Refsum, H., Heiland, S., and Ueland, P. M. Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patients receiving low-dose methotrexate treatment. Clin. Pharmacol. Ther., 46: 510-520, 1989.
16. Refsum, H., Wesenberg, F., and Ueland, P. M. Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate. Cancer Res., 51: 828-835, 1991.
17. Morgan, S. L., Baggott, J. E., Refsum, H., and Ueland, P. M. Homocysteine levels in rheumatoid arthritis patients treated with low-dose methotrexate. Clin. Pharmacol. Ther., 50: 547-556, 1991.
18. Fiskerstrand, T., Refsum, H., Kvalheim, G., and Ueland, P. M. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin. Chem., 39: 263-271, 1993.
19. Mansoor, M. A., Bergmark, C., Svardal, A. M., Lønning, P. E., and Ueland, P. M. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler. Thromb. Vasc. Biol., 15: 232-240, 1995.
20. Raghunathan, K., Schmitz, J. C., and Priest, D. G. Impact of schedule on leucovorin potentiation of fluorouracil antitumor activity in dietary folic acid deplete mice. Biochem. Pharmacol., 53: 1197-1202, 1997.
21. Guttormsen, A. B., Mansoor, A. M., Fiskerstrand, T., Ueland, P. M., and Refsum, H. Kinetics of plasma homocysteine in healthy subjects after peroral homocysteine loading. Clin. Chem., 39: 1390-1397, 1993.
22. Guttormsen, A. B., Schneede, J., Ueland, P. M., and Refsum, H. Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency. Am. J. Clin. Nutr., 63: 194-202, 1996.
23. Nygård, O., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M., and Vollset, S. E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med., 337: 230-236, 1997.